Abstract
Purpose
This paper presents our 18 years of experience in treating ACTH secreting adenomas (Cushing’s disease and Nelson’s syndrome) using the Leksell gamma knife (LGK) irradiation.
Methods
Twenty-six patients with Cushing’s disease were followed-up after LGK irradiation for 48–216 months (median 78 months). Seventeen patients had undergone previous surgery, in nine patients LGK irradiation was the primary therapy. Furthermore, 14 patients with Nelson’s syndrome were followed-up for 30–204 months (median 144 months).
Results
LGK treatment resulted in hormonal normalization in 80.7 % of patients with Cushing’s disease. Time to normalization was 6–54 months (median 30 months). The volume of the adenoma decreased in 92.3 % (in 30.7 % disappeared completely). There was no recurrence of the disease. In all 14 patients with Nelson’s syndrome ACTH levels decreased (in two patients fully normalized) their ACTH levels. When checked up 5–10 years after irradiation regrowth of the adenoma was only detected in one patient (9.1 %), in 27.3 % adenoma volume remained unchanged, in 45.4 % adenoma volume decreased and in 18.2 % adenoma completely disappeared. Hypopituitarism did not develop in any patient where the critical dose to the pituitary and distal infundibulum was respected.
Conclusion
LGK radiation represents an effective and well-tolerated option for the treatment of patients with Cushing’s disease after unsuccessful surgery and may be valuable even as a primary treatment in patients who are not suitable for, or refuse, surgery. In the case of Nelson’s syndrome it is possible to impede tumorous growth and control the size of the adenoma in almost all patients.
Similar content being viewed by others
References
Biller BMK, Grosssman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay LR, Newel-Price J, Nieman LK, Petersenn S, Sonino N, Stalla K, Swearingen B, Vance ML, Waas JAH, Boscaro M (2008) Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 93:2454–2462
Minniti G, Osti M, Jaffrain-Rea ML, Esposito V, Cantore G, Maurizi Enrici R (2007) Long-term follow up results of postoperative radiation therapy for Cushing’s disease. J Neurooncol 84:79–84
Starke RM, Williams BJ, Vance ML, Sheehan JP (2010) Radiation therapy and stereotactic radiosurgery for the treatment of Cushing’s disease: an evidence-based review. Curr Opin Endocrinol Diabetes Obes 17:356–364
Ježková J, Marek J, Hána V, Kršek M, Weiss V, Vladyka V, Liščák R, Vymazal J, Pecen L (2006) Gamma knife radiosurgery for acromegaly—long-term experience. Clin Endocrinol 64:588–595
Ježková J, Hána V, Kršek M, Weiss V, Vladyka V, Liščák R, Vymazal J, Pecen L, Marek J (2009) Use of the Leksell gamma knife in the treatment of prolactinoma patients. Clin Endocrinol 70:732–741
Liščák R, Vladyka V, Marek J, Šimonová G, Vymazal J (2007) Gamma knife radiosurgery for endocrine-inactive pituitary adenomas. Acta Neurochir 149:999–1006
Brada M, Ajithkumar TV, Minniti G (2004) Radiosurgery for pituitary adenomas. Clin Endocrinol 61:531–543
Minniti G, Brada M (2007) Radiotherapy and radiosurgery for Cushing’s disease. Arq Bras Endocrinol Metabol 51:1373–1380
Oldfield EH (2010) Unresolved issues: radiosurgery versus radiation therapy; medical suppression of growth hormone production during radiosurgery; and endoscopic surgery versus microscopic surgery. Neurosurg Focus 29:E16
Novotný J Jr, Vymazal J, Novotný J, Tlachačová D, Schmitt M, Chuda P, Ugrošík D, Liščák R (2005) Does new magnetic resonance imaging technology provide better geometrical accuracy during stereotactic imaging?. J Neurosurg 102(Suppl):8–13
Marek J, Ježková J, Hána V, Kršek M, Bandúrová L, Pecen L, Vladyka V, Liščák R (2011) Is it possible to avoid hypopituitarism after irradiation of pituitary adenomas by the Leksell gamma knife? Eur J Endocrinol 164:169–178
Swords FM, Monson JP, Besser GM, Chew SL, Drake WM, Grossman AB, Plowman PN (2009) Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy. Eur J Endocrinol 161:819–828
Kobayashi T, Kida Y, Mori Y (2002) Gamma knife radiosurgery in the treatment of Cushing disease: long-term results. J Neurosurg 97(Suppl 5):422–428
Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L, Vance ML (2007) Gamma knife surgery for Cushing’s disease. J Neurosurg 106:980–987
Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML (2011) Gamma knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 114:303–309
Pollock BE, Brown PD, Nippolt TB, Young WF Jr (2008) Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomas. Neurosurgery 62:1271–1278
Wan H, Chihiro O, Yuan S (2009) MASEP gamma knife radiosurgery for secretory pituitary adenomas: experience in 347 consecutive cases. J Exp Clin Cancer Res 28:36–44
Castro DG, Cecilio SAJ, Canteras MM (2010) Radiosurgery for pituitary adenomas: evaluation of its efficacy and safety. Radiat Oncol 5:109–115
Höybye C, Grenbäck E, Rähn T, Degerblad M, Thorén M, Hulting AL (2001) Adrenocorticotropic hormone-producing tumors: 12 to 22-year follow up after treatment with stereotactic radiosurgery. Neurosurgery 49:284–291
Vladyka V, Liščák R, Novotný J Jr, Marek J, Ježková J (2003) Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas. Neurosurgery 52:309–317
Leenstra JL, Tanaka S, Kline RW, Brown PD, Link MJ, Nippoldt TB, Young WF Jr, Pollock BE (2010) Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomas. Neurosurgery 67:27–32
Feigl GC, Pistracher K, Berghold A, Mokry M (2010) Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas: the role of hypothalamus. J Neurosurg 113(Suppl.):153–159
Sicignano G, Losa M, del Vecchio A, Cattaneo GM, Picozzi P, Bolognesi A, Mortini P, Calandrino R (2012) Dosimetric factors associated with pituitary function after gamma knife surgery (GKS) of pituitary adenomas. Radiother Oncol 104:119–124
Loeffler JS, Shih HA (2011) Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab 96:1992–2003
Pollock BE (2012) Comparing radiation therapy and radiosurgery for pituitary adenoma patients. World Neurosurg 78:58–59
Minniti G, Traish D, Ashley S, Gonsalves A, Brada M (2005) Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma. J Clin Endocrinol Metab 90:800–804
Rowe J, Grainger A, Walton L, Silcocks P, Radatz M, Kemeny A (2007) Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery 60:60–65
Kajiwara K, Saito K, Yoshikawa K, Ideguchi M, Nomura S, Fujii M, Suzuki M (2010) Sterotactic radiosurgery/radiotherapy for pituitary adenomas: a review of recent literature. Neurol Med Chir 50:749–755
Kim W, Clelland C, Yang I, Poratian N (2012) Comprehensive review of stereotactic radiosurgery for medically and surgically refractory pituitary adenomas. Surg Neurol Int 3(Suppl. 2):S79–S89
Pollock BE, Young WF Jr (2002) Stereotactic radiosurgery for patients with ACTH—producing pituitary adenomas after prior adrenalectomy. Int J Radiation Oncol Biol Phys 54:839–841
Vik-Mo EO, Øksnes M, Pedersen P-H, Wentzel-Larsen T, Rodahl E, Thorsen F, Schreiner T, Aanderud S, Lund-Johansen M (2009) Gamma knife stereotactic radiosurgery of Nelson’s syndrome. Eur J Endocrinol 160:143–148
Sheehan JP, Zhiyuan X, Salvetti DJ, Schmitt PJ, Lee Vance MJ (2013) Results of gamma knife surgery for Cushing’s disease. J Neurosurg 119:1486–1492
Pollock BE, Nippoldt TB, Stafford SL, Foote RL, Abboud CF (2002) Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization. J Neurosurg 97:525–530
Jane JA, Vance ML, Woodburn CJ, Laws ER Jr (2003) Sterotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach. Neurosurg Focus 14:e12
Castinetti F, Nagai M, Dufour H, Kuh J-M, Morange I, Jaquet P, Conte-Devolx B, Regis J, Brue T (2007) Gamma knife radiosurgery is a successful adjunctive treatment in Cushing’s disease. Eur J Endocrinol 156:91–98
Tinnel BA, Henderson MA, Witt TC, Fakiris AJ, Worth RM, Des Rosiers PM, Edmondson JW, Timmerman RD, Lo SS (2006) Endocrine response after gamma knife—based sterotactic radiosurgery for secretory pituitary adenoma. Sterotact Funct Neurosurg 86:292–296
Losa M, Picozzi P, Redaelli MG, Laurenzi A, Mortini P (2010) Pituitary radiotherapy for Cushing’s disease. Neuroendocrinology 92(Suppl 1):107–110
Wolffenbutell BH, Kitz K, Beuls EM (1998) Beneficial gamma-knife radiosurgery in a patient with Nelson’s syndrome. Clin Neurol Neurosurg 100:60–63
Mauermann WJ, Sheehan JP, Chernavvsky DR, Steiner L, Vance ML (2007) Gamma knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy. J Neurosurg 106:988–993
Acknowledgments
This work was supported by the Research Program of Charles University in Prague, Czech Republic, P25/LF1/2.
Conflict of interest
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marek, J., Ježková, J., Hána, V. et al. Gamma knife radiosurgery for Cushing’s disease and Nelson’s syndrome. Pituitary 18, 376–384 (2015). https://doi.org/10.1007/s11102-014-0584-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-014-0584-7